FDA: Montelukast Tablet Bottles Recalled

Share this content:
FDA: Montelukast Tablet Bottles Recalled
FDA: Montelukast Tablet Bottles Recalled

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.

Bottles labeled as containing 30 tablets of 10-milligram montelukast sodium tablets instead contain 90 tablets of losartan potassium tablets.

There is a safety risk because taking losartan when not prescribed can cause renal dysfunction, elevated potassium levels, and low blood pressure. The risk can be especially high for pregnant woman because losartan could harm or kill the fetus, the FDA said Friday.

The recalled bottles have the following lot numbers: MON17384, expiration date: 12/31/2019, and NDC: 31722-726-30. Patients who have the recalled bottles should contact their health care provider or pharmacist immediately, the FDA said.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Case Numbers of U.S. Children With Polio-Like Illness Hit Record High

Case Numbers of U.S. Children With Polio-Like Illness ...

CDC says there have been 158 confirmed cases of acute flaccid myelitis in 36 states

Paid Childbearing Policies Lacking for Residents

Paid Childbearing Policies Lacking for Residents

Policies optimizing competing goals and defining training competency needed

is free, fast, and customized just for you!




Already a member?

Sign In Now »